Now online: the GE Healthcare and Abbott co-sponsored scientific Satellite Symposium at EULAR 2012: “Treat to Target: What are the benefits of a targeted ultrasound approach?”
According to the symposium chairman Paul Emery, “Imaging modalities are critical for the early diagnosis and monitoring of RA. Application of tools such as sonography in conjunction with T2T principles may further improve clinical outcomes.”
Watch the three webcasts here.
This article describes something very important the benefits of a targeted ultrasound, can save your life.
Regards,
Kevin
Posted by: Kevin | Monday, August 13, 2012 at 18:15